In order to assess the relationship between the concentrations of S100A6, MMP-9 and CST4 in tear samples and the individual’s pathological status, we tested the correlation between the presence of the biomarkers and RA (Figure 3). The gene discussed is S100A6; the disease is rheumatoid arthritis.